Get a Quote

We’ll review your message and have a quote for you within the next business day.

Follow Us on LinkedIn

Our Take Blog

bezuclastinib + sunitinib base case Figure.png

July 14, 2026

Cogent’s bezuclastinib reduces risk of disease progression or death by 50% in 2L metastatic GIST when combined with standard of care

July 14, 2026

July 14, 2026

Ind2 - Chemo (TROP-2) vs Datroway Figure.png

July 1, 2026

TROP2 ADCs: A Major Innovation for 1L TNBC

July 1, 2026

July 1, 2026

TP53 Pathway LinkedIn HQ.jpg

June 11, 2026

TP53, the most altered gene in oncology

June 11, 2026

June 11, 2026